Owing to its potential of reducing lung injury associated with mechanical ventilation, the use of noninvasive respiratory support, particularly nasal continuous positive airway pressure (nCPAP), has become a common strategy for early respiratory management of preterm infants.
1,2 In recent years, heated, humidified high-flow nasal cannula (HHHFNC) has increased in popularity in high-resource countries as an alternative form of noninvasive respiratory support for newborn infants.
3-5 In contrast to nCPAP, for which the rationale is essentially based on the provision of a continuous distending pressure, multiple mechanisms have been suggested to explain HHHFNC functioning, such as washout of the nasopharyngeal dead space, optimal gas conditioning, and provision of a variable distending pressure.
6-9 The HHHFNC approach has been applied in the neonatal intensive care unit (NICU) in a variety of clinical situations: weaning from nCPAP,
10 preventing apnea of prematurity,
11 following extubation,
3,4,12-14 and as primary therapy for respiratory distress syndrome (RDS).
15 Compared with nCPAP, HHHFNC offers ease of use,
16 reduced risk of nasal injuries,
17 better infant tolerance with improved feeding, and bonding.
18,19